Biogen has been trying to build up its R&D pipeline as it faces increased competition for its biggest-selling products like ...

Overview of Short Bowel Syndrome MarketThe Global Short Bowel Syndrome Market is valued at USD 1.76 Billion in 2024 and is projected to attain a value of USD 3.66 Billion by 2035 at a CAGR of 6.91% ...

An instructor of medicine is concerned cannabis hyperemesis syndrome (CHS) is being diagnosed too often without a proper ...

Pervasive stigma around cannabis use is leading some ER doctors to overdiagnose a rare marijuana-related syndrome.

After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...